In FY2023, the company recorded a net margin of 0.6%, compared to a net margin of 24.5% in FY2022. The company reported revenues of US$16,112 million for the second quarter ended June 2024, an ...

In FY2023, the company recorded a net margin of 0.6%, compared to a net margin of 24.5% in FY2022. The company reported revenues of US$16,112 million for the second quarter ended June 2024, an ...

Beyond Good and Evil 2 hasn't stopped development yet, and despite a lack of evidence, it is still apparently in the works at Ubisoft Montpellier. 16 years since this upcoming action-adventure ...

Merck (NYSE:MRK) reported positive Phase 2 data from its waveLINE-007 trial evaluating its antibody drug conjugate zilovertamab vedotin in the treatment of diffuse large B-cell lymphoma ...

RAHWAY, N.J., December 09, 2024--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the Phase 3 KEYLYNK-001 trial evaluating KEYTRUDA ...

The study evaluated zilovertamab vedotin, the ADC Merck acquired in its $2.75 billion VelosBio buyout four years ago. Investigators enrolled 36 people with previously untreated diffuse large B ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the first presentation of data from the Phase 2 waveLINE-007 trial ...

“Moana 2” is still making a splash at the domestic box office. The Disney animated sequel added $11.7 million on Friday, on its way to $50.8 million for its second weekend of release.

DualityBio saw responses in 56.2% of the 73 patients with small cell lung cancer (SCLC), an indication in which Merck and Daiichi Sankyo are at the front of the pack. The DualityBio result ...

Merck & Co., Inc. (NYSE:MRK) will increase its dividend from last year's comparable payment on the 8th of January to $0.81. This will take the annual payment to 3.2% of the stock price ...